Manufacturing methods for liposome adjuvants

Yvonne Perrie*, Elisabeth Kastner, Swapnil Khadke, Carla B. Roces, Peter Stone

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

12 Citations (Scopus)

Abstract

A wide range of studies have shown that liposomes can act as suitable adjuvants for a range of vaccine antigens. Properties such as their amphiphilic character and biphasic nature allow them to incorporate antigens within the lipid bilayer, on the surface, or encapsulated within the inner core. However, appropriate methods for the manufacture of liposomes are limited and this has resulted in issues with cost, supply, and wider scale application of these systems. Within this chapter we explore manufacturing processes that can be used for the production of liposomal adjuvants, and we outline new manufacturing methods can that offer fast, scalable, and cost-effective production of liposomal adjuvants.

Original languageEnglish
Title of host publicationVaccine Adjuvants
Subtitle of host publicationMethods and Protocols
EditorsChristopher B. Fox
Place of PublicationNew York
PublisherSpringer New York
Pages127-144
Number of pages18
ISBN (Print)978-1-4939-6443-7
DOIs
Publication statusPublished - 8 Oct 2016

Publication series

NameMethods in Molecular Biology
Volume1494
ISSN (Print)10643745

Keywords

  • adjuvants
  • delivery system
  • liposomes
  • manufacturing
  • preparation
  • subunit vaccine

Fingerprint

Dive into the research topics of 'Manufacturing methods for liposome adjuvants'. Together they form a unique fingerprint.

Cite this